Prominent businessmen who lobbied hard for budget funding for type 1 diabetes (T1D) technology were deeply disappointed by their lack of success last week, but are not deterred.
“You can never give up arguing the logic of this”, says Jeff Browne.
Loading...
Jill Margo was a senior writer at The Australian Financial Review.
